Litigation Details for SUN PHARMACEUTICAL INDUSTRIES, LTD. v. NOVARTIS PHARMACEUTICALS CORP. (D.N.J. 2019)
✉ Email this page to a colleague
SUN PHARMACEUTICAL INDUSTRIES, LTD. v. NOVARTIS PHARMACEUTICALS CORP. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-12-20 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-05-14 |
| Cause | Assigned To | Claire Claudia Cecchi | |
| Jury Demand | Referred To | Mark Falk | |
| Patents | 6,284,804; 6,359,016; 8,846,650; 9,149,486; 9,345,714; 9,402,805 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUN PHARMACEUTICAL INDUSTRIES, LTD. v. NOVARTIS PHARMACEUTICALS CORP.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SUN PHARMACEUTICAL INDUSTRIES, LTD. v. NOVARTIS PHARMACEUTICALS CORP. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-12-19 | 1 | Complaint | . 6,284,804 (“the ’804 patent”), U.S. Patent No. 6,359,016 (“the ’016 patent”), the ’650 patent, the … claim of U.S. Patent Nos. 9,402,805 (“the ’805 patent”), 9,345,714 (“the ’714 patent”), 9,149,486 (“…(“the ’486 patent”), and 8,846,650 (the ’650 patent”) and the claims of the ‘805 patent are invalid for…action regarding allegations of patent infringement arising under the patent laws of the United States, Title…certifications for each patent listed in the Orange Book for the RLD: (i) there are no patents listed in the Orange | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
